Evidence map›Paper›PMID 24976383›Full record

ArticleNature cell biology2014

Increased microtubule assembly rates influence chromosomal instability in colorectal cancer cells.

Norman Ertych, Ailine Stolz, Albrecht Stenzinger, Wilko Weichert, Silke Kaulfuß, Peter Burfeind, Achim Aigner, Linda Wordeman, Holger Bastians

Open access · greenAbstract read
In one paragraph

Article in Nature cell biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 132 papers.

0numbers the graph read from it
0cells of the map it votes in
132citing papers in PubMed
9.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

132 citing papers in PubMed, 222 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The liver talks back: NPY orchestrates attraction of cancer cells and CHK2-dependent clonogenicity in the metastatic niche.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  10. Article
  11. Article
  12. Modulation of the cytoskeleton for cancer therapy.Frontiers in cell and developmental biology · 2025
    Article
  13. Article
  14. Computational analysis of treatment resistant cancer cells.Frontiers in cell and developmental biology · 2025
    Article
  15. Microtubule regulation in cancer cells.Frontiers in cell and developmental biology · 2025
    Article
  16. Microtubule poleward flux as a target for modifying chromosome segregation errors.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  17. Article
  18. Article
  19. Review
  20. Article

72 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Norman Ertych1] Institute of Molecular Oncology, Section for Cellular Oncology, Goettingen Center for Molecular Biosciences (GZMB) and University Medical Center, Georg-August University, D-37077 Goettingen, Germany [2].
Ailine Stolz1] Institute of Molecular Oncology, Section for Cellular Oncology, Goettingen Center for Molecular Biosciences (GZMB) and University Medical Center, Georg-August University, D-37077 Goettingen, Germany [2].
Albrecht StenzingerInstitute for Pathology, University Medical Center, Ruprecht-Karls-University, D-69120 Heidelberg, Germany.
Wilko Weichert1] Institute for Pathology, University Medical Center, Ruprecht-Karls-University, D-69120 Heidelberg, Germany [2] German Consortium for Translational Cancer Research, D-69120 Heidelberg, Germany.
Silke KaulfußInstitute for Human Genetics, University Medical Center, Georg-August University, D-37073 Goettingen, Germany.
Peter BurfeindInstitute for Human Genetics, University Medical Center, Georg-August University, D-37073 Goettingen, Germany.
Achim AignerRudolf-Boehm-Institute for Pharmacology and Toxicology, Clinical Pharmacology, University of Leipzig, D-04107 Leipzig, Germany.
Linda WordemanDepartment of Physiology and Biophysics, University of Washington, School of Medicine, Seattle, Washington 98195, USA.
Holger BastiansInstitute of Molecular Oncology, Section for Cellular Oncology, Goettingen Center for Molecular Biosciences (GZMB) and University Medical Center, Georg-August University, D-37077 Goettingen, Germany.
University of Göttingen · DEHeidelberg University · DELeipzig University · DEUniversity Hospital Heidelberg · DEUniversity of Washington · US

Funding

Microtubule Dynamics and Chromosome SegregationR01GM069429 · NIGMS · UNIVERSITY OF WASHINGTON · PI WORDEMAN, LINDA · 2004 to 2020
$5.6M
Microtuble-dependent markers for chromosome instabilityR21CA174527 · NCI · UNIVERSITY OF WASHINGTON · PI WORDEMAN, LINDA · 2014 to 2015
$370k
NCI NIH HHS R21 CA174527NIGMS NIH HHS GM069429NIGMS NIH HHS R01 GM069429
6 · The paper itself

Abstract

Chromosomal instability (CIN) is defined as the perpetual missegregation of whole chromosomes during mitosis and represents a hallmark of human cancer. However, the mechanisms influencing CIN and its consequences on tumour growth are largely unknown. We identified an increase in microtubule plus-end assembly rates as a mechanism influencing CIN in colorectal cancer cells. This phenotype is induced by overexpression of the oncogene AURKA or by loss of the tumour suppressor gene CHK2, a genetic constitution found in 73% of human colorectal cancers. Increased microtubule assembly rates are associated with transient abnormalities in mitotic spindle geometry promoting the generation of lagging chromosomes and influencing CIN. Reconstitution of proper microtubule assembly rates by chemical or genetic means suppresses CIN and thereby, unexpectedly, accelerates tumour growth in vitro and in vivo. Thus, we identify a fundamental mechanism influencing CIN in cancer cells and reveal its adverse consequence on tumour growth.

Indexed as

Chromosomal InstabilityAurora Kinase ABRCA1 ProteinCaco-2 CellsCell Line, TumorCheckpoint Kinase 2Chromosome SegregationColorectal NeoplasmsGene ExpressionGenes, Tumor SuppressorHCT116 CellsHT29 CellsHumansMicrotubulesModels, BiologicalOncogenesAURKA protein, humanAurora Kinase ABRCA1 ProteinBRCA1 protein, humanCheckpoint Kinase 2CHEK2 protein, human

Identifiers

PMID24976383
PMCPMC4389786
OpenAlexW1988963409

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.